Search Results - "JASPERSE, B"

Personalized biomechanical tongue models based on diffusion-weighted MRI and validated using optical tracking of range of motion by Kappert, K. D. R., Voskuilen, L., Smeele, L. E., Balm, A. J. M., Jasperse, B., Nederveen, A. J., van der Heijden, F.

“…For advanced tongue cancer, the choice between surgery and organ-sparing treatment is often dependent on the expected loss of tongue functionality after…”
Get full text

Long-term neuroprotective effects of natalizumab and fingolimod in multiple sclerosis: Evidence from real-world clinical data by Noteboom, S., Strijbis, E.M.M., Coerver, E.M.E., Colato, E., van Kempen, Z.L.E., Jasperse, B., Vrenken, H., Killestein, J., Schoonheim, M.M., Steenwijk, M.D.

“…•Effect of high efficacy therapy on brain atrophy was investigated on clinical MRI.•Natalizumab slowed ventricular growth the most (1.1 %/year).•Patients…”
Get full text

Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis by ALTMANN, D. R, JASPERSE, B, WAGNER, K, YOUSRY, T. A, MILLER, D. H, BARKHOF, F, BECKMANN, K, FILIPPI, M, KAPPOS, L. D, MOLYNEUX, P, POLMAN, C. H, POZZILLI, C, THOMPSON, A. J

“…Progressive brain atrophy in multiple sclerosis (MS) may reflect neuroaxonal and myelin loss and MRI measures of brain tissue loss are used as outcome measures…”
Get full text

Predicting short-term disability progression in early multiple sclerosis: added value of MRI parameters by Minneboo, A, Jasperse, B, Barkhof, F, Uitdehaag, B M J, Knol, D L, de Groot, V, Polman, C H, Castelijns, J A

“…Objective: Magnetic resonance imaging (MRI) and clinical parameters are associated with disease progression in multiple sclerosis (MS). The aim of this study…”
Get full text

Recurrent oropharyngeal cancer after organ preserving treatment: pattern of failure and survival by de Ridder, M., Gouw, Z. A. R., Sonke, J. J., Navran, A., Jasperse, B., Heukelom, J., Tesselaar, M. E. T., Klop, W. M. C., van den Brekel, M. W. M., Al-Mamgani, Abrahim

“…The objectives is to thoroughly analyze the pattern of failure and oncologic outcome in recurrent oropharyngeal cancer (OPC) after (chemo)radiotherapy and…”
Get full text

Long-term clinical outcome of primary progressive MS : Predictive value of clinical and MRI data by SASTRE-GARRIGA, J, INGLE, G. T, BARKHOF, F, BROCHET, B, DOUSSET, V, FILIPPI, M, MONTALBAN, X, KALKERS, N. F, POLMAN, C. H, ROVIRA, A, MILLER, D. H, THOMPSON, A. J, ROVARIS, M, TELLEZ, N, JASPERSE, B, ALTMANN, D. R, BENEDETTI, B, STEVENSON, V. L, CERCIGNANI, M, LEARY, S. M

“…The authors sought to identify clinical and MRI predictors of outcome in primary progressive multiple sclerosis (PPMS). Clinical and MRI assessments were…”
Get full text

Very late delayed-allergic reaction to natalizumab not associated with neutralizing antibodies by Killestein, J, Jasperse, B, Liedorp, M, Seewann, A, Polman, CH

Get full text

Growth-associated protein 43 in lesions and cerebrospinal fluid in multiple sclerosis by Teunissen, C. E., Dijkstra, C. D., Jasperse, B., Barkhof, F., Vanderstichele, H., Vanmechelen, E., Polman, C. H., Bö, L.

“…Axonal damage in multiple sclerosis (MS) is correlated to disease progression. Early axonal damage may be compensated for by regenerative processes…”
Get full text

The Effect of Tumor Volume Changes on the Boost-Volume Coverage in Glioblastoma Patients by Hessen, E., Nijkamp, J., Troost, E., Makocki, S., de Jong, M., Dewit, L.H.G., Jasperse, B., van der Heide, U., Borst, G.

Get full text

LBA40 Neoadjuvant nivolumab and nivolumab plus ipilimumab induce (near-) complete responses in patients with head and neck squamous cell carcinoma: The IMCISION trial by Zuur, L., Vos, J.L., Elbers, J.B., Krijgsman, O., Qiao, X., van der Leun, A., Smit, L., van den Brekel, M.W., Tan, B., Jasperse, B., Vogel, W.V., Willems, S.M., Al-Mamgani, A., Peeper, D., Schumacher, T.N., Blank, C.U., de Boer, J.P., Haanen, J.B.A.G.

Get full text

PO-0987: Target volume changes of brain metastases during fractionated SRS by Hessen, E., Damen, P., Jasperse, B., Dewit, L., Elkhuizen, P., Van Mourik, A., Wittkamper, F., Damen, E., Van der Heide, U., Hanssens, P., Schasfoort, J., Nijkamp, J., Borst, G.

Get full text

OS4.2 Radiological response assessment in the era of bevacizumab: RANO or volumetry? A report from the BELOB trial by Gahrmann, R., van den Bent, M., van der Holt, B., Vernhout, R., Taal, W., Taphoorn, M., de Groot, J., Beerepoot, L., Jasperse, B., Smits, M.

Get full text

NIMG-13. RADIOLOGICAL RESPONSE ASSESSMENT IN THE ERA OF BEVACIZUMAB: RANO OR VOLUMETRY? A REPORT FROM THE BELOB TRIAL by Gahrmann, Renske, Bent, Martin van den, Holt, B. van der, Vernhout, R., Taal, W., Taphoorn, Martin, de Groot, J.C., Beerepoot, L., Buter, J., Flach, Z., Hanse, M., Jasperse, B., Smits, Marion

Get full text

Surgical nurse practitioner as first assistant and more by Jasperse, M B

Get more information

Sample sizes for brain atrophy outcome measures in clinical trials for secondary progressive multiple sclerosis by Altmann, D, Jasperse, B, Barkhof, F, Beckmann, K, Filippi, M, Kappos, L, Molyneux, P, Polman, CH, Pozzilli, C, Thompson, A J, Wagner, K, Yousry, T, Miller, D H

“…Background: Progressive brain atrophy in multiple sclerosis (MS) may reflect neuroaxonal and myelin loss and magnetic resonance imaging (MRI) measures of brain…”
Get full text

Champions the OR by Jasperse, Mary B., Halsell, Marilyn

Get full text